Benzydamine HCl for Postoperative Sore Throat
POST
Efficacy of Benzydamine Hydrochloride Dripping at Endotracheal Tube Cuff for Prevention of Postoperative Sore Throat
1 other identifier
interventional
86
1 country
1
Brief Summary
To evaluate the analgesic effect of benzydamine hydrochloride dripping on the endotracheal tube cuff for postoperative sore throat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 7, 2012
CompletedFirst Posted
Study publicly available on registry
July 11, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedJuly 26, 2012
July 1, 2012
1.5 years
July 7, 2012
July 25, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
analgesic effect
evaluate pain score for sore throat at 0, 2, 4, 6, 12 and 24 hours after the operation
24 hours
Secondary Outcomes (1)
side effects of benzydamine hydrochloride
24 hours
Study Arms (2)
nothing
NO INTERVENTIONnothing will be dripped on the cuff of the endotracheal tube in the control group
benzydamine HCl
EXPERIMENTALbenzydamine HCl will be dripped on the cuff of the endotracheal tube 5 minutes before induction of general anesthesia
Interventions
3 ml (4.5 mg) of benzydamine hydrochloride will be dripped on the cuff of the endotracheal tube 5 minutes prior to induction of general anesthesia
Eligibility Criteria
You may qualify if:
- Patients aged 18-65 years
- ASA status I-II
- Mallampati grade I-II
- Duration of surgery less than 4 hours
- Patients placed in the supine position
You may not qualify if:
- Undergoing oral, cervical spine or thyroid surgery
- More than one attempt of ETT intubation or intubated with a technique of rapid sequence induction with cricoid pressure
- Insertion of nasogastric/orogastric tube or esophageal stethoscope
- Complaint of sore throat or hoarseness
- Presence of upper respiratory tract infection within 7 days prior to the operation
- Gastroesophageal reflux
- Known allergy to benzydamine hydrochloride or other nonsteroidal anti-inflammatory drugs (NSAIDs)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, 90110, Thailand
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sasikaan - Nimmaanrat, MD
Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110 Thailand
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 7, 2012
First Posted
July 11, 2012
Study Start
January 1, 2011
Primary Completion
July 1, 2012
Study Completion
August 1, 2012
Last Updated
July 26, 2012
Record last verified: 2012-07